Description
BLOOD AND BLOOD REALTED PRODUCTS
First action · last action
2011-01-01 · 2012-05-18
Transactions
2
First transaction's obligation
$424,998
Base + all options value (sum of deltas)
$401,685
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-01-01+$424,998= $424,998
- Mod P000012012-05-18-$23,313= $401,685
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-01-01 | +$424,998 | $424,998 | BLOOD AND BLOOD REALTED PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2012-05-18 | −$23,313 | $401,685 | BLOOD AND BLOOD REALTED PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RFL7D3RDNTN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0225 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $483,336 | FY2026 |
| 36C25726N0141 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,879,193 | FY2026 |
| 36C25725N0173 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $475,040 | FY2025 |
| 36C25725N0172 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $996,312 | FY2025 |
| 36C25724N0180 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $919,065 | FY2024 |
| 36C25724N0098 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $163,033 | FY2024 |
Other recipients under Q523 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25713C0014 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 549-DALLAS | $1,449,000 | FY2013 |
| VA25712J0455 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 549-DALLAS | $1,382,838 | FY2012 |
| VA25712D0021 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 549-DALLAS | $0 | FY2012 |
| V549C10586 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 549-DALLAS | $569,672 | FY2011 |
| VA549C10053 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 549-DALLAS | $10,086 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25712D0039_3600_-NONE-_-NONE- · retrieved 2026-09-26.